Hans Hillege

Molecular and Cellular Biologist Profile

Molecular and Cellular Biologist

Discover our research

- Quantitative Benefit-Risk AssessmentHans Hillege (Speaker), Douwe Postmus (Speaker) 26-Aug-2018 Professional or public presentation > Professional
- Benefit-risk evaluation in drug licensing decisions: current European statusHans Hillege (Speaker) 17-Jan-2018 Professional or public presentation > Professional
- Netherlands Society of Cardiology/Nederlandse Vereniging voor Cardiologie (NVVC) (External organisation)Hans Hillege (Member) 1-Jan-2018 Membership > Professional
All activities